Until her results are rendered significant with baseline and post surgical comparisons, I don't think the market in general will have a big response. Especially institutions are very skeptical about the stem cell industry - they'll want real proof before they'll allow themselves optimism. We should, over the next few weeks, see small increase in buying from individual investors who know what this indicates - but they aren't likely to make huge difference in sp. They should hold it steady for us though.
News 
Market Data 
Discover 
